Lumida
/RCUS
⌘K
Arcus Biosciences Inc

Arcus Biosciences Inc

RCUS
$24.59USD-5.97%-1.56 today

MARKET CAP

3.1B

P/E (TTM)

FWD P/E

DAY RANGE

$24 – $27

52W RANGE

$11
$32

AI Summary

Stalk
Sell NowMedium

RCUS is in Stage 3 distribution and has triggered a support failure pattern with price closing sharply below key intra-month support on high volume, signaling committed selling. Short-term momentum is negative with price rejected at the 9/20/50 EMAs and approaching the 200-day SMA, while the long-term uptrend remains intact above the rising 200-day SMA. The medium-term bias is bearish, and negative short-term conditions favor immediate downside participation. A decisive reclaim of the broken support band and EMAs would invalidate the bearish posture.

  • Management forecasts $5–10B peak sales for casdatifan in RCC market
  • $775M cash as of Q2 2026 funds operations into H2 2028 amid R&D spending cuts
  • Q2 2026 net loss of $91M and full-year revenue guidance of $65–75M underscore weak profitability
Full analysis →
Insider Trades53 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jul 9, 2026SellRCUSJuan C. JaenPresident68,569$29.63$3.1B-22.51%+117.61%$2.0M-2.68%Buy Now
Jun 22, 2026SellRCUSJuan C. JaenPresident31,431$27.92$3.1B-22.51%+117.61%$877.5K-0.87%10b5-1Buy Now
Jun 11, 2026BuyRCUSCarolyn C. TangGeneral Counsel34,090$2.57$3.1B-22.51%+117.61%$87.7K+22.65%Buy Now
Jun 1, 2026SellRCUSAlexander AzoyChief Accounting Officer2,562$25.77$3.1B-22.51%+117.61%$66.0K-6.08%Buy Now
May 11, 2026SellRCUSIi Robert C. GoeltzChief Financial Officer7,763$25.63$3.1B-22.51%+117.61%$199.0K-8.45%Buy Now
Jan 8, 2026SellRCUSTerry J RosenChief Executive Officer35,000$21.35$3.1B-22.51%+117.61%$747.3K-1.60%Buy Now
Jan 5, 2026SellRCUSJuan C. JaenPresident31,823$21.41$3.1B-22.51%+117.61%$681.3K-1.14%Buy Now
Dec 31, 2025SellRCUSIi Robert C. GoeltzChief Financial Officer6,552$23.38$3.1B-22.51%+117.61%$153.2K-8.80%10b5-1Buy Now
Dec 30, 2025SellRCUSTerry J RosenChief Executive Officer2,400$23.23$3.1B-22.51%+117.61%$55.8K-0.11%Buy Now
Dec 16, 2025SellRCUSAlexander AzoyChief Accounting Officer8,832$22.13$3.1B-22.51%+117.61%$195.4K-11.74%Buy Now
Dec 16, 2025SellRCUSRichard MarkusChief Medical Officer9,546$22.01$3.1B-22.51%+117.61%$210.1K-6.57%Buy Now
Dec 16, 2025SellRCUSIi Robert C. GoeltzChief Financial Officer12,662$22.01$3.1B-22.51%+117.61%$278.7K-7.56%Buy Now
Dec 16, 2025SellRCUSCarolyn C. TangGeneral Counsel14,468$22.01$3.1B-22.51%+117.61%$318.5K-5.34%Buy Now
Dec 16, 2025SellRCUSJuan C. JaenPresident21,208$22.01$3.1B-22.51%+117.61%$466.9K-2.93%Buy Now
Dec 16, 2025SellRCUSJennifer JarrettChief Operating Officer21,208$22.01$3.1B-22.51%+117.61%$466.9K-5.08%Buy Now
Dec 16, 2025SellRCUSTerry J RosenChief Executive Officer54,691$22.01$3.1B-22.51%+117.61%$1.2M-1.22%Buy Now
Dec 4, 2025SellRCUSJuan C. JaenPresident82,997$24.71$3.1B-22.51%+117.61%$2.1M-8.00%Buy Now
Nov 26, 2025SellRCUSAlexander AzoyChief Accounting Officer3,800$19.66$3.1B-22.51%+117.61%$74.7K+0.00%Buy Now
Nov 26, 2025SellRCUSIi Robert C. GoeltzChief Financial Officer5,000$25.00$3.1B-22.51%+117.61%$125.0K-5.43%Buy Now
Nov 17, 2025SellRCUSJuan C. JaenPresident50,000$20.26$3.1B-22.51%+117.61%$1.0M-1.57%Buy Now
Nov 7, 2025SellRCUSJennifer JarrettChief Operating Officer100,582$10.10$3.1B-22.51%+117.61%$1.0M+0.00%Buy Now
Oct 30, 2025SellRCUSJuan C. JaenPresident4,314$20.32$3.1B-22.51%+117.61%$87.6K-0.40%Buy Now
Oct 28, 2025SellRCUSIi Robert C. GoeltzChief Financial Officer5,000$20.00$3.1B-22.51%+117.61%$100.0K-5.15%Buy Now
Oct 28, 2025SellRCUSJuan C. JaenPresident96,859$20.76$3.1B-22.51%+117.61%$2.0M-2.12%Buy Now
Oct 6, 2025SellRCUSJennifer JarrettChief Operating Officer100,584$8.07$3.1B-22.51%+117.61%$812.2K+0.00%Buy Now
Sep 29, 2025SellRCUSAlexander AzoyChief Accounting Officer2,831$13.00$3.1B-22.51%+117.61%$36.8K-9.38%Buy Now
Sep 5, 2025SellRCUSAlexander AzoyChief Accounting Officer1,579$11.88$3.1B-22.51%+117.61%$18.8K-4.97%Buy Now
Feb 27, 2025BuyRCUSTerry J RosenChief Executive Officer19,800$10.18$3.1B-22.51%+117.61%$201.5K+0.78%Buy Now
Dec 31, 2024SellRCUSIi Robert C. GoeltzChief Financial Officer3,594$15.00$3.1B-22.51%+117.61%$53.9K-5.64%Buy Now
Dec 15, 2024SellRCUSAlexander AzoyChief Accounting Officer2,969$16.08$3.1B-22.51%+117.61%$47.7K-15.57%Buy Now
Dec 15, 2024SellRCUSDimitry Sa NuytenChief Medical Officer7,856$16.08$3.1B-22.51%+117.61%$126.3K-8.24%Buy Now
Dec 15, 2024SellRCUSIi Robert C. GoeltzChief Financial Officer10,099$16.08$3.1B-22.51%+117.61%$162.4K-13.68%Buy Now
Dec 15, 2024SellRCUSCarolyn C. TangGeneral Counsel11,339$16.08$3.1B-22.51%+117.61%$182.3K-10.13%Buy Now
Dec 15, 2024SellRCUSJuan C. JaenPresident17,286$16.08$3.1B-22.51%+117.61%$278.0K-5.17%Buy Now
Dec 15, 2024SellRCUSJennifer JarrettChief Operating Officer27,501$16.08$3.1B-22.51%+117.61%$442.2K-14.41%Buy Now
Dec 15, 2024SellRCUSTerry J RosenChief Executive Officer37,882$16.08$3.1B-22.51%+117.61%$609.1K-1.57%Buy Now
Dec 2, 2024SellRCUSAlexander AzoyChief Accounting Officer201$15.32$3.1B-22.51%+117.61%$3.1K-1.04%Buy Now
Sep 15, 2024SellRCUSDimitry Sa NuytenChief Medical Officer5,385$17.95$3.1B-22.51%+117.61%$96.7K-5.37%Buy Now
Sep 15, 2024SellRCUSJennifer JarrettChief Operating Officer12,670$17.95$3.1B-22.51%+117.61%$227.4K-6.24%Buy Now
Aug 13, 2024SellRCUSAlexander AzoyChief Accounting Officer1,357$14.97$3.1B-22.51%+117.61%$20.3K-6.64%Buy Now
Jun 15, 2024SellRCUSCarolyn C. TangGeneral Counsel4,182$16.97$3.1B-22.51%+117.61%$71.0K-3.62%Buy Now
Jun 15, 2024SellRCUSJuan C. JaenPresident6,969$16.97$3.1B-22.51%+117.61%$118.3K-2.04%Buy Now
Jun 15, 2024SellRCUSJennifer JarrettChief Operating Officer12,670$16.97$3.1B-22.51%+117.61%$215.0K-5.87%Buy Now
Jun 15, 2024SellRCUSTerry J RosenChief Executive Officer12,670$16.97$3.1B-22.51%+117.61%$215.0K-0.32%Buy Now
Mar 27, 2024SellRCUSJennifer JarrettChief Operating Officer11,551$17.55$3.1B-22.51%+117.61%$202.7K-5.09%Buy Now
Mar 18, 2024SellRCUSJennifer JarrettChief Operating Officer13,449$17.92$3.1B-22.51%+117.61%$240.9K-2.87%Buy Now
Feb 26, 2024SellRCUSJuan C. JaenPresident27,032$20.09$3.1B-22.51%+117.61%$543.2K-1.11%Buy Now
Feb 26, 2024SellRCUSJennifer JarrettChief Operating Officer58,625$20.09$3.1B-22.51%+117.61%$1.2M-10.23%Buy Now
Jan 2, 2024SellRCUSIi Robert C. GoeltzChief Financial Officer2,004$20.00$3.1B-22.51%+117.61%$40.1K-3.72%Buy Now
Jan 2, 2024SellRCUSJuan C. JaenPresident6,975$20.09$3.1B-22.51%+117.61%$140.1K-0.57%Buy Now
Dec 22, 2023SellRCUSJennifer JarrettChief Operating Officer21,521$17.76$3.1B-22.51%+117.61%$382.2K-7.68%Buy Now
Dec 1, 2023SellRCUSAlexander AzoyChief Accounting Officer282$14.95$3.1B-22.51%+117.61%$4.2K-2.37%Buy Now
Sep 22, 2023SellRCUSJennifer JarrettChief Operating Officer21,369$19.99$3.1B-22.51%+117.61%$427.2K-6.59%Buy Now